Condensed Consolidated Statements Of Shareholders' Equity - USD ($) $ in Millions	Total	Common Stock [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Common stock, balance, beginning of period at Feb. 02, 2019		$ 3,048
Common stock
Issuance of common stock under stock compensation plans		19
Stock-based compensation		39
Common stock, balance, end of period at Nov. 02, 2019	$ 3,106	3,106
Accumulated deficit, balance, beginning of period at Feb. 02, 2019			$ (2,138)
Accumulated deficit
Cumulative effect of adopted accounting standards			(25)
Net earnings (loss)	304		304
Dividends			(172)
Repurchase of common stock			(186)
Accumulated deficit, balance, end of period at Nov. 02, 2019	(2,217)		(2,217)
Accumulated other comprehensive loss, balance, beginning of period at Feb. 02, 2019				$ (37)
Accumulated other comprehensive loss
Other comprehensive income (loss)				(1)
Accumulated other comprehensive loss, balance, end of period at Nov. 02, 2019	(38)			(38)
Total Shareholders’ Equity at Nov. 02, 2019	$ 851
Accumulated other comprehensive loss
Dividends per share	$ 1.11
Common stock, balance, beginning of period at Aug. 03, 2019		3,084
Common stock
Issuance of common stock under stock compensation plans		8
Stock-based compensation		14
Common stock, balance, end of period at Nov. 02, 2019	$ 3,106	3,106
Accumulated deficit, balance, beginning of period at Aug. 03, 2019			(2,286)
Accumulated deficit
Cumulative effect of adopted accounting standards			0
Net earnings (loss)	126		126
Dividends			(57)
Repurchase of common stock			0
Accumulated deficit, balance, end of period at Nov. 02, 2019	(2,217)		(2,217)
Accumulated other comprehensive loss, balance, beginning of period at Aug. 03, 2019				(39)
Accumulated other comprehensive loss
Other comprehensive income (loss)				1
Accumulated other comprehensive loss, balance, end of period at Nov. 02, 2019	(38)			(38)
Total Shareholders’ Equity at Nov. 02, 2019	$ 851
Accumulated other comprehensive loss
Dividends per share	$ 0.37
Common stock, balance, beginning of period at Feb. 01, 2020	$ 3,129	3,129
Common stock
Issuance of common stock under stock compensation plans		16
Stock-based compensation		45
Common stock, balance, end of period at Oct. 31, 2020	3,190	3,190
Accumulated deficit, balance, beginning of period at Feb. 01, 2020	(2,082)		(2,082)
Accumulated deficit
Cumulative effect of adopted accounting standards			0
Net earnings (loss)	(723)		(723)
Dividends			(58)
Repurchase of common stock			0
Accumulated deficit, balance, end of period at Oct. 31, 2020	(2,863)		(2,863)
Accumulated other comprehensive loss, balance, beginning of period at Feb. 01, 2020	(68)			(68)
Accumulated other comprehensive loss
Other comprehensive income (loss)				(7)
Accumulated other comprehensive loss, balance, end of period at Oct. 31, 2020	(75)			(75)
Total Shareholders’ Equity at Oct. 31, 2020	$ 252
Accumulated other comprehensive loss
Dividends per share	$ 0.37
Common stock, balance, beginning of period at Aug. 01, 2020		3,168
Common stock
Issuance of common stock under stock compensation plans		5
Stock-based compensation		17
Common stock, balance, end of period at Oct. 31, 2020	$ 3,190	$ 3,190
Accumulated deficit, balance, beginning of period at Aug. 01, 2020			(2,916)
Accumulated deficit
Cumulative effect of adopted accounting standards			0
Net earnings (loss)	53		53
Dividends			0
Repurchase of common stock			0
Accumulated deficit, balance, end of period at Oct. 31, 2020	(2,863)		$ (2,863)
Accumulated other comprehensive loss, balance, beginning of period at Aug. 01, 2020				(78)
Accumulated other comprehensive loss
Other comprehensive income (loss)				3
Accumulated other comprehensive loss, balance, end of period at Oct. 31, 2020	(75)			$ (75)
Total Shareholders’ Equity at Oct. 31, 2020	$ 252
Accumulated other comprehensive loss
Dividends per share	$ 0